Details for New Drug Application (NDA): 202496
✉ Email this page to a colleague
The generic ingredient in ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 202496
Tradename: | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE |
Applicant: | Ritedose Corp |
Ingredient: | albuterol sulfate; ipratropium bromide |
Patents: | 0 |
Pharmacology for NDA: 202496
Mechanism of Action | Adrenergic beta2-Agonists Cholinergic Antagonists |
Suppliers and Packaging for NDA: 202496
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 202496 | ANDA | Mylan Pharmaceuticals Inc. | 0378-9671 | 0378-9671-30 | 1 POUCH in 1 CARTON (0378-9671-30) / 30 AMPULE in 1 POUCH (0378-9671-64) / 3 mL in 1 AMPULE |
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 202496 | ANDA | Mylan Pharmaceuticals Inc. | 0378-9671 | 0378-9671-60 | 2 POUCH in 1 CARTON (0378-9671-60) / 30 AMPULE in 1 POUCH / 3 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.083% BASE;0.017% | ||||
Approval Date: | Oct 1, 2012 | TE: | AN | RLD: | No |
Complete Access Available with Subscription